Here are five Johnson & Johnson investments:
- The venture capital arm led a $78 million funding round for Perceive Therapeutics, a biotech company focusing in ophthalmology.
- HistoSonics, the developer of a sonic beam therapy, received $85 million in a funding round led by Johnson & Johnson innovation.
- In December, Johnson & Johnson joined in a $60.75 million series A funding round for SonoThera, a biotech genetic therapy company.
- Johnson & Johnson Innovation participated in the $25 million series B funding round for medical device cybersecurity company MedCrypt.
- The venture capital arm co-led a $10 million funding round for DocSpera, a surgical workflow automation company.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
